Paper12964166
Synthesis, structural and biological studies of ubiquitin mutants containing (2S, 4S)-5-fluoroleucine residues strategically placed in the hydrophobic core.
Alexeev D and 17 others. Chembiochem, 2003. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Synthesis, structural and biological studies of ubiquitin mutants containing (2S, 4S)-5-fluoroleucine residues strategically placed in the hydrophobic core. Papers, record 12964166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12964166
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Synthesis, structural and biological studies of ubiquitin mutants containing (2S, 4S)-5-fluoroleucine residues strategically placed in the hydrophobic core.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Leucine | Major topic |
| Protein Engineering | Major topic |
| Ubiquitins | Major topic |
| Magnetic Resonance Spectroscopy | |
| Mutation | |
| Protein Conformation | |
| Protein Denaturation | |
| Protein Folding | |
| Solubility | |
| Stereoisomerism |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| B20089 | Biotechnology and Biological Sciences Research Council | United Kingdom | PubMed |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40704089 | Inter-residue through-space scalar 19F-19F couplings between CH2F groups in a protein. | Magn Reson (Gott) | 2025 | https://conductscience.org/library/papers/40704089 | PubMed |
| 37197608 | Development of a single culture E. coli expression system for the enzymatic synthesis of fluorinated tyrosine and its incorporation into proteins. | J Fluor Chem | 2022 | https://conductscience.org/library/papers/37197608 | PubMed |
| 35755190 | Fluorine-induced polarity increases inhibitory activity of BPTI towards chymotrypsin. | RSC Chem Biol | 2022 | https://conductscience.org/library/papers/35755190 | PubMed |
| 32817054 | Regulatory effects of post-translational modifications on zDHHC S-acyltransferases. | J Biol Chem | 2020 | https://conductscience.org/library/papers/32817054 | PubMed |
| 24391900 | Protein structure validation and refinement using amide proton chemical shifts derived from quantum mechanics. | PLoS One | 2013 | https://conductscience.org/library/papers/24391900 | PubMed |
| 23932201 | Fluorine-19 NMR of integral membrane proteins illustrated with studies of GPCRs. | Curr Opin Struct Biol | 2013 | https://conductscience.org/library/papers/23932201 | PubMed |
| 21117055 | Chemical synthesis of ubiquitin, ubiquitin-based probes, and diubiquitin. | Angew Chem Int Ed Engl | 2010 | https://conductscience.org/library/papers/21117055 | PubMed |
| 17915350 | Solution structure of a small protein containing a fluorinated side chain in the core. | Protein Sci | 2007 | https://conductscience.org/library/papers/17915350 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12964166
GET https://conductscience.org/api/papers/v1/12964166/authors